Fig. 11

Pathology after 12 weeks of administration of JFBX (×400). C3: Control, heart, Male No.3; M3: Model, heart, Male No.3; L3: JFBX low-dose, heart, Male No.3; H3: JFBX high-dose, heart, Male No.3; S1: Hematological characteristics including WBC, RBC, and HGB counts; S2: the area of the cardiac cells.